Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Top Ten Equity Holdings and Exposures

2nd Dec 2025 17:00

RNS Number : 9508J
Polar Capital Global Health Tst PLC
02 December 2025
 

2nd December 2025

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 28th November 2025

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 28th November 2025 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings

%

Eli Lilly & Co

9.6%

AstraZeneca

5.2%

Thermo Fisher Scientific

4.4%

Teva Pharmaceutical Industries

4.2%

CVS Health Corp

3.8%

UCB

3.3%

Boston Scientific Corp

3.3%

H Lundbeck A/S

3.2%

Cytokinetics

2.9%

Ascendis Pharma A/S

2.6%

Total

42.5%

 

Sector Exposure

%

Pharmaceuticals

36.1%

Biotechnology

22.3%

Healthcare Equipment

13.5%

Life Sciences Tools & Services

9.0%

Healthcare Services

8.9%

Healthcare Facilities

4.2%

Managed Healthcare

2.3%

Healthcare Distributors

1.3%

Healthcare Technology

0.9%

Healthcare Supplies

0.0%

Cash

1.6%

Total

100.0%

 

Geographic Exposure

%

United States

53.2%

Denmark

12.0%

United Kingdom

5.2%

Switzerland

5.0%

Israel

4.2%

Germany

4.2%

India

3.7%

Belgium

3.3%

Japan

3.3%

Netherlands

1.6%

Sweden

1.4%

Ireland

1.3%

Cash

1.6%

Total

100.0%

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUPGRAPUPAGQP

Related Shares:

Polar Cap Glbl
FTSE 100 Latest
Value9,693.30
Change-8.50